Buy Clearside Biomedical Stock | CLSD Stock Price & Latest News | Public
CLSD

Clearside Biomedical

$0.00 (0.00%)Today
    Small Market Cap

    About CLSD

    Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.04
    -0.09
    -0.13
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.11

    Actual EPS
    Q4 2020

    Stats

    Market Cap$94,29M
    Volume12,42k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.13
    1 Year Low$1.10
    Open$2.00
    High$2.01
    Low$1.68

    Buy any stock with any amount of money.

    Download the App
    Download the app